Search Results 391-400 of 16980 for rbc

1. Rasburicase (intravenous route) - Side effects & uses - Mayo Clinic

   Glucose-6-phosphate dehydrogenase (G6PD) deficiency (a hereditary metabolic disorder affecting red blood cells)—Should not be used in patients with these ...

2. A novel risk score may help urologists determine which patients with kidney stones require urgent intervention - Mayo Clinic

   Such infections require urgent decompression in the form of ureteral stent or nephrostomy tube placement. In the setting of truly infected urine, these ...

3. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   Note: Transfusion (red blood cell or platelet) or G-CSF administration is not allowed within 14 days prior to the day on which marrow function is assessed ...

4. A Study Using Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Post Cardiopulmonary Bypass Surgery Clotting Problems and Bleeding - Mayo Clinic

   ... red blood cell alloimmunization, and 4) hemolytic transfusion reactions. The effects of pathogen inactivation or reduction methods on these risks are also ...

5. Adenomyosis - Symptoms & causes - Mayo Clinic

   Heavy bleeding during periods from adenomyosis could lead to anemia. Anemia occurs when there aren't enough healthy red blood cells to carry oxygen to the ...

6. A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients - Mayo Clinic

   Previously treated, with an approved JAK inhibitor for PMF or Post-PV/ET MF for ≥ 90 days, or ≥ 28 days if JAK inhibitor therapy is complicated by RBC ...

7. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

   Note: no platelet transfusion, packed red blood cell transfusion, or G-CSF will be allowed during the screening phase after ICF signature. Participant must ...

8. A Multicenter Study Using Cryoablation for the Palliation of Painful Bone Metastases - Mayo Clinic

   ... red cells as a function of cooling and warming velocities. Miller RH. R H; Mazur P. P. Cryobiology. 1976. Aug; 13(4):404-14. Human red cells were ...

9. Loncastuximab Tesirine in WM - Mayo Clinic

   RBC transfusions are not permitted <14 days prior to C1D1. - Total bilirubin ≤ 1.5 X ULN, or ≤3 x ULN with documented liver metastases and/or. Gilbert's ...

10. The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach - Mayo Clinic

    Active urinary sediment, defined as microscopic hematuria (>5 red blood cells per high power field) or red blood cell casts. D. Granulomatosis inflammation ...